Kwality Pharmaceuticals Limited has disclosed changes to its Board of Directors in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Schedule III of the SEBI Listing Regulations and SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024.

Appointment of New Director

The Board of Directors, based on the recommendation of the Nomination and Remuneration Committee, appointed Mr. Swanith Kapoor (DIN: 11662482) as Additional (Non-Executive, Independent) Director of the Company.

  • Term of appointment: 5 years from June 02, 2026 to June 01, 2031 (both days inclusive)
  • Appointment is subject to approval by the Shareholders of the Company
  • The company confirms that Mr. Kapoor satisfies the criteria of independence prescribed under the Companies Act, 2013 and SEBI Listing Regulations
  • He is not debarred from holding the office of Director by virtue of any order passed by SEBI or any other authority

Director Profile

Mr. Swanith Kapoor is a qualified legal professional with the following credentials:

  • Holds B.B.A. LL.B. (Hons.) with specialization in Corporate Law from the School of Law, University of Petroleum and Energy Studies, Dehradun, Uttrakhand
  • Awarded the University Silver Medal
  • Completed Post Graduate Diploma in Medical Law and Ethics from NLSIU, Bengaluru
  • Currently pursuing Master's in Business Laws from NLSIU, Bengaluru
  • Worked as Legal Intern with TCS, Mumbai and Dhir & Dhir Law Offices, New Delhi
  • Not related to any existing Director of the Company

Resignation of Director

Mr. Kartik Kapur (DIN: 08966816) has tendered his resignation as an Independent Director of the Company, effective from close of business hours on June 02, 2026.

  • Reason for resignation: Other professional commitments
  • The resigning director confirmed there are no material reasons other than those mentioned in the resignation letter
  • Mr. Kapur does not hold directorship and membership of any board committees of any other listed company
  • The Board placed on record its sincere appreciation for Mr. Kapur's valuable contributions and guidance during his tenure